|
ASPM expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.20694598549198E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.82079999966334E-08 |
| Normal-vs-Stage2 |
1.72162999999559E-05 |
| Normal-vs-Stage3 |
5.60730351040206E-11 |
| Normal-vs-Stage4 |
4.57920000029866E-07 |
| Stage1-vs-Stage2 |
4.885800E-01 |
| Stage1-vs-Stage3 |
9.938600E-03 |
| Stage1-vs-Stage4 |
9.786800E-04 |
| Stage2-vs-Stage3 |
2.248400E-01 |
| Stage2-vs-Stage4 |
4.063200E-03 |
| Stage3-vs-Stage4 |
2.024500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64324109874769E-12 |
| Normal-vs-AfricanAmerican |
1.517950E-03 |
| Normal-vs-Asian |
1.307380E-01 |
| Caucasian-vs-AfricanAmerican |
2.255100E-03 |
| Caucasian-vs-Asian |
7.003600E-01 |
| AfricanAmerican-vs-Asian |
3.570600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.18522985764957E-13 |
| Normal-vs-Female |
6.39890029852097E-10 |
| Male-vs-Female |
1.055020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.157900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.89930005056738E-09 |
| Normal-vs-Age(61-80Yrs) |
2.02449168540397E-12 |
| Normal-vs-Age(81-100Yrs) |
1.823980E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.228600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.461600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.641900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.378600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.146300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.353760E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.835300E-03 |
| Normal-vs-Grade 2 |
9.08260000542782E-09 |
| Normal-vs-Grade 3 |
2.96007662825559E-12 |
| Normal-vs-Grade 4 |
2.57930000002737E-06 |
| Grade 1-vs-Grade 2 |
2.424800E-03 |
| Grade 1-vs-Grade 3 |
2.05529999999232E-05 |
| Grade 1-vs-Grade 4 |
1.446220E-04 |
| Grade 2-vs-Grade 3 |
4.122100E-02 |
| Grade 2-vs-Grade 4 |
2.415300E-03 |
| Grade 3-vs-Grade 4 |
1.070270E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.43480000103224E-08 |
| Normal-vs-ccB subtype |
4.60631532916977E-13 |
| ccA subtype-vs-ccB subtype |
2.812200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.75769978969254E-10 |
| Normal-vs-N1 |
8.968600E-04 |
| N0-vs-N1 |
1.396320E-03 |
|
|
